Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis.
Emerg Microbes Infect
; 11(1): 1154-1165, 2022 12.
Article
en En
| MEDLINE
| ID: mdl-35343397
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Tratamiento Farmacológico de COVID-19
Tipo de estudio:
Clinical_trials
/
Systematic_reviews
Límite:
Humans
Idioma:
En
Revista:
Emerg Microbes Infect
Año:
2022
Tipo del documento:
Article